Cargando…
The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever
Colchicine is the treatment of choice in familial Mediterranean fever (FMF) for the prevention of both attacks and secondary amyloidosis. The overall nonresponder rate is about 5–10%. Anakinra is known to have good effectiveness in a severe autoinflammatory syndrome [chronic infantile neurological c...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Springer-Verlag
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292480/ https://www.ncbi.nlm.nih.gov/pubmed/17588171 http://dx.doi.org/10.1007/s00431-007-0547-3 |